448 related articles for article (PubMed ID: 31815615)
21. Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous population.
Adcock A; Cram F; Lawton B; Geller S; Hibma M; Sykes P; MacDonald EJ; Dallas-Katoa W; Rendle B; Cornell T; Mataki T; Rangiwhetu T; Gifkins N; Hart S
Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):301-307. PubMed ID: 30614524
[TBL] [Abstract][Full Text] [Related]
22. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
23. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
[TBL] [Abstract][Full Text] [Related]
24. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
25. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
26. Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.
Ilangovan K; Kobetz E; Koru-Sengul T; Marcus EN; Rodriguez B; Alonzo Y; Carrasquillo O
J Womens Health (Larchmt); 2016 Sep; 25(9):944-51. PubMed ID: 26890012
[TBL] [Abstract][Full Text] [Related]
27. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
28. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
[TBL] [Abstract][Full Text] [Related]
29. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
30. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
[TBL] [Abstract][Full Text] [Related]
31. Barriers to cervical screening and interest in self-sampling among women who actively decline screening.
Bennett KF; Waller J; Chorley AJ; Ferrer RA; Haddrell JB; Marlow LA
J Med Screen; 2018 Dec; 25(4):211-217. PubMed ID: 29649936
[TBL] [Abstract][Full Text] [Related]
32. Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population.
Chatzistamatiou K; Chatzaki Ε; Constantinidis Τ; Nena E; Tsertanidou A; Agorastos T
J Obstet Gynaecol; 2017 Nov; 37(8):1059-1064. PubMed ID: 28631511
[TBL] [Abstract][Full Text] [Related]
33. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
[TBL] [Abstract][Full Text] [Related]
34. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
35. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
[TBL] [Abstract][Full Text] [Related]
36. A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
Lawton B; MacDonald EJ; Storey F; Stanton JA; Adcock A; Gibson M; Parag V; Sparkes NK; Kaimoana B; King F; Terry M; Watson H; Bennett M; Lambert CS; Geller S; Paasi I; Hibma M; Sykes P; Hawkes D; Saville M
JMIR Res Protoc; 2023 Sep; 12():e51643. PubMed ID: 37707939
[TBL] [Abstract][Full Text] [Related]
37. He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Māori women talk about HPV self-testing cervical screening clinical pathways.
Adcock A; Stevenson K; Cram F; MacDonald EJ; Geller S; Hermens J; Lawton B
Int J Gynaecol Obstet; 2021 Nov; 155(2):275-281. PubMed ID: 34382217
[TBL] [Abstract][Full Text] [Related]
38. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
39. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
[TBL] [Abstract][Full Text] [Related]
40. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
